Method for producing a polypeptide using a cell that overexpresses a bicarbonate transporter. JOB1 en. PTT en. SGA1 en. Method for producing cells producing high production of heterologous protein. ARA1 en. Retention of antigen-binding molecules in blood plasma and method for modifying immunogenicity. Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly. Monoclonal antibody with liver cancer resisting activity and application thereof.
TWA en. MXB en. Antigen-binding molecule for promoting disappearance of antigen via fc gamma riib. BRA2 en. An antigen-binding molecule that promotes elimination of an antigen containing a sugar chain receptor-binding domain from plasma. INDNA en. SGXA en. Bispecific antibody aiming at phosphatidylinositols protein polysaccharide-3 and T cell antigen.
Radiolabeled anti-glypican-3 immunoconjugates for immuno-pet imaging of hepatocellular carcinoma. Gpc3-targeting drug which is administered to patient responsive to gpc3-targeting drug therapy.
MAA en. For preparing artificial semiantigen, preparation method and the monoclonal antibody of acquisition of glypican-3 GPC3 monoclonal antibody.
JPWOA1 en. The preparation method of nano-probe, the preparation method and application of Nano medication based on natural products monomer and nano-probe. Method for preparing quantum dots with nuclear shell structures, fluorescent nanometer probe for target tumor markers GPC-3 and method for preparing fluorescent nanometer probe. Method for assisting prediction of recurrence risk in hepatocellular carcinoma patient, and use of a kit.
EPA4 en. JPA en. Undifferentiated stem cell removing agent and method of removing undifferentiated stem cells. AUA1 en. Methods and compositions relating to anti-CHI3L1 antibody reagents to treat cancer. SGWA en.
EPA1 en. SGRA en. Antigen binding molecule comprising antigen binding domain whose binding activity to antigen is changed by MTA and library for obtaining the same. Formulation, dosage regimen, and manufacturing process for heterodimeric fc-fused proteins. JPHB2 en. USA en. JPHA en. Production and use of transgenic, non-human animals capable of forming heterologous antibodies. AUA en. Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same.
HUB1 en. Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells. CZA3 en. Nucleic acid and amino acid sequences relating to Enterococcus faecalis for diagnostics and therapeutics.
USB1 en. EPA3 en. Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity. Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies.
DET2 en. CAA1 en. Antibody glycosylation variants having increased anti-body-dependent cellular cytotoxicity. WOA2 en. ITBOU1 en.
Integrin antagonists with enhanced antibody dependent cell-mediated cytotoxicity activity. And more. Game modes Campaigns. Campaigns Dive into a complete series of linear missions! With varying difficulty levels these are perfect for beginners and veterans alike. Scenarios There are loads of scenarios that stick to certain themes, enabling any driving enthusiast can find something that speaks to them. Complete a truck delivery request as fast and efficiently as possible, or outrun police cruisers in a hot pursuit.
Time-trials Choose a vehicle, environment, and route and put yourself to the test! Refine your skills and compete against yourself while improving your best time. Freeroam Don't want to feel limited? Take any vehicle to a destination of choice and start exploring. Experimentation is also key in this game mode, as objects and environmental conditions can be manipulated. Try revving up wind speeds for a challenge, or altering gravity!
0コメント